BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garhart CA, Nedrud JG, Heinzel FP, Sigmund NE, Czinn SJ. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun. 2003;71:3628-3633. [PMID: 12761151 DOI: 10.1128/iai.71.6.3628-3633.2003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology. 2010;138:1046-1054. [PMID: 19931266 DOI: 10.1053/j.gastro.2009.11.043] [Cited by in Crossref: 194] [Cited by in F6Publishing: 200] [Article Influence: 14.9] [Reference Citation Analysis]
2 Taylor JM, Ziman ME, Canfield DR, Vajdy M, Solnick JV. Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog. 2008;44:20-27. [PMID: 17683897 DOI: 10.1016/j.micpath.2007.06.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
3 Taylor JM, Ziman ME, Fong J, Solnick JV, Vajdy M. Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun 2007;75:3462-9. [PMID: 17502399 DOI: 10.1128/IAI.01470-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
4 Otsu S, Gotoh K, Yamashiro T, Yamagata J, Shin K, Fujioka T, Nishizono A. Transfer of antigen-pulsed dendritic cells induces specific T-Cell proliferation and a therapeutic effect against long-term Helicobacter pylori infection in mice. Infect Immun 2006;74:984-93. [PMID: 16428744 DOI: 10.1128/IAI.74.2.984-993.2006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
5 Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, Matsumoto Y, Chiba T, Fuss IJ, Kitani A, Strober W. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest. 2010;120:1645-1662. [PMID: 20389019 DOI: 10.1172/jci39481] [Cited by in Crossref: 160] [Cited by in F6Publishing: 105] [Article Influence: 13.3] [Reference Citation Analysis]
6 Peng X, Zhang R, Wang C, Yu F, Yu M, Chen S, Fan Q, Xi Y, Duan G. E. coli Enterotoxin LtB Enhances Vaccine-Induced Anti-H. pylori Protection by Promoting Leukocyte Migration into Gastric Mucus via Inflammatory Lesions. Cells 2019;8:E982. [PMID: 31461854 DOI: 10.3390/cells8090982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Gorrell RJ, Robins-Browne RM. Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect Immun 2009;77:5116-29. [PMID: 19737910 DOI: 10.1128/IAI.00547-09] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Ben Suleiman Y, Yoshida M, Nishiumi S, Tanaka H, Mimura T, Nobutani K, Yamamoto K, Takenaka M, Aoganghua A, Miki I, Ota H, Takahashi S, Matsui H, Nakamura M, Blumberg RS, Azuma T. Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice. Mucosal Immunol 2012;5:87-98. [PMID: 22089027 DOI: 10.1038/mi.2011.53] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
9 Utsch C, Haas R. VacA's Induction of VacA-Containing Vacuoles (VCVs) and Their Immunomodulatory Activities on Human T Cells. Toxins (Basel). 2016;8. [PMID: 27322323 DOI: 10.3390/toxins8060190] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
10 Zawahir S, Czinn SJ, Nedrud JG, Blanchard TG. Vaccinating against Helicobacter pylori in the developing world. Gut Microbes. 2013;4:568-576. [PMID: 24253617 DOI: 10.4161/gmic.27093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
11 Yan J, Luo YH, Mao YF. Establishment of Helicobacter pylori infection model in Mongolian gerbils. World J Gastroenterol 2004; 10(6): 852-855 [PMID: 15040031 DOI: 10.3748/wjg.v10.i6.852] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
12 Dohi T, Fujihashi K, Koga T, Etani Y, Yoshino N, Kawamura YI, McGhee JR. CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis. Am J Pathol 2004;165:1257-68. [PMID: 15466391 DOI: 10.1016/S0002-9440(10)63385-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 Chonwerawong M, Avé P, Huerre M, Ferrero RL. Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice. Gut Pathog 2016;8:61. [PMID: 27895717 DOI: 10.1186/s13099-016-0142-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Müller A, Oertli M, Arnold IC. H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell Commun Signal. 2011;9:25. [PMID: 22044597 DOI: 10.1186/1478-811x-9-25] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
15 Gorrell RJ, Wijburg OL, Pedersen JS, Walduck AK, Kwok T, Strugnell RA, Robins-Browne RM. Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori. Infect Immun 2013;81:3880-93. [PMID: 23918779 DOI: 10.1128/IAI.01424-12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rasool KH, Mahmood Alubadi AE, Al-Bayati IFI. The role of Serum Interleukin-4 and Interleukin-6 in Helicobacter pylori-infected patients. Microb Pathog 2021;162:105362. [PMID: 34942310 DOI: 10.1016/j.micpath.2021.105362] [Reference Citation Analysis]
17 Sjökvist Ottsjö L, Flach CF, Nilsson S, Malefyt Rde W, Walduck AK, Raghavan S. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection. PLoS One 2015;10:e0131444. [PMID: 26168305 DOI: 10.1371/journal.pone.0131444] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
18 Larussa T, Leone I, Suraci E, Imeneo M, Luzza F. Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance. J Immunol Res. 2015;2015:981328. [PMID: 26525279 DOI: 10.1155/7015/981328] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Larussa T, Leone I, Suraci E, Imeneo M, Luzza F. Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance. J Immunol Res. 2015;2015:981328. [PMID: 26525279 DOI: 10.1155/2015/981328] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
20 Ding H, Nedrud JG, Wershil B, Redline RW, Blanchard TG, Czinn SJ. Partial protection against Helicobacter pylori in the absence of mast cells in mice. Infect Immun. 2009;77:5543-5550. [PMID: 19822650 DOI: 10.1128/iai.00532-09] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
21 Moyat M, Velin D. Immune responses to Helicobacter pylori infection. World J Gastroenterol 2014; 20(19): 5583-5593 [PMID: 24914318 DOI: 10.3748/wjg.v20.i19.5583] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
22 Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev. 2006;19:597-613. [PMID: 17041136 DOI: 10.1128/cmr.00006-06] [Cited by in Crossref: 159] [Cited by in F6Publishing: 80] [Article Influence: 9.9] [Reference Citation Analysis]
23 Kotiw M, Johnson M, Pandey M, Fry S, Hazell SL, Netter HJ, Good MF, Olive C. Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model. Clin Vaccine Immunol 2012;19:268-76. [PMID: 22205658 DOI: 10.1128/CVI.05295-11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
24 Xue RY, Guo MF, Guo L, Liu C, Li S, Luo J, Nie L, Ji L, Ma CJ, Chen DQ, Sun S, Jin Z, Zou QM, Li HB. Synthetic Lipopeptide Enhances Protective Immunity Against Helicobacter pylori Infection. Front Immunol 2019;10:1372. [PMID: 31258538 DOI: 10.3389/fimmu.2019.01372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]